Showing results (181-190 of 235) with videos related to

Sort By:
Pageof 24
Journal of Neuromuscular Diseases|January 22, 2024
Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE RegistryLaurent Servais, John W Day, Darryl C De Vivo, et al.
Human Mutation|June 29, 2010
LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhoodCaroline Michot, Laurence Hubert, Michèle Brivet, et al.
Journal of Neuromuscular Diseases|December 3, 2016
Type 0 Spinal Muscular Atrophy: Further Delineation of Prenatal and Postnatal Features in 16 PatientsSarah Grotto, Jean-Marie Cuisset, Stéphane Marret, et al.
Neurology. Genetics|April 11, 2025
Spectrum of Phenotypes in SMA Patients With 4 <i>SMN2</i> Copies in the French Population: Registre SMA FranceLorène Gerin, Juliette Ropars, Rocío Garcia-Uzquiano, et al.
Brain : a Journal of Neurology|March 22, 2006
Delineation of the motor disorder of Lesch-Nyhan diseaseH A Jinnah, Jasper E Visser, James C Harris, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 23, 2024
Long-Term Clinical and Biological Prognostic Factors of Anti-NMDA Receptor Encephalitis in ChildrenMaxime Mazowiecki, Lorraine Flet-Berliac, Julia Roux, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Mutation in a primate-conserved retrotransposon reveals a noncoding RNA as a mediator of infantile encephalopathyFrançois Cartault, Patrick Munier, Edgar Benko, et al.
Neurology|December 28, 2012
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPANPenelope Hogarth, Allison Gregory, Michael C Kruer, et al.
Skeletal Muscle|December 15, 2015
CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophyFernanda Pinto-Mariz, Luciana Rodrigues Carvalho, Alexandra Prufer De Queiroz Campos Araujo, et al.
Pageof 24